Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Improved Antibiotic Prescribing within a Veterans Affairs Primary Care System through a Multifaceted Intervention Centered on Peer Comparison of Overall Antibiotic Prescribing Rates.

Shively NR, Buehrle DJ, Wagener MM, Clancy CJ, Decker BK.

Antimicrob Agents Chemother. 2019 Nov 4. pii: AAC.00928-19. doi: 10.1128/AAC.00928-19. [Epub ahead of print]

PMID:
31685466
2.

Point-of-use filters for prevention of health care-acquired Legionnaires' disease: Field evaluation of a new filter product and literature review.

Parkinson J, Baron JL, Hall B, Bos H, Racine P, Wagener MM, Stout JE.

Am J Infect Control. 2019 Oct 24. pii: S0196-6553(19)30821-1. doi: 10.1016/j.ajic.2019.09.006. [Epub ahead of print]

PMID:
31668765
3.

Inflammasome expression and cytomegalovirus viremia in critically ill patients with sepsis.

Singh N, Inoue M, Osawa R, Wagener MM, Shinohara ML.

J Clin Virol. 2017 Aug;93:8-14. doi: 10.1016/j.jcv.2017.05.012. Epub 2017 May 18.

4.

Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem.

Singh N, Sifri CD, Silveira FP, Miller R, Gregg KS, Huprikar S, Lease ED, Zimmer A, Dummer JS, Spak CW, Koval C, Banach DB, Shroff M, Le J, Ostrander D, Avery R, Eid A, Razonable RR, Montero J, Blumberg E, Alynbiawi A, Morris MI, Randall HB, Alangaden G, Tessier J, Cacciarelli TV, Wagener MM, Sun HY.

Med Mycol. 2017 Apr 1;55(3):278-284. doi: 10.1093/mmy/myw079.

PMID:
27601609
5.

Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients.

Singh N, Winston DJ, Limaye AP, Pelletier S, Safdar N, Morris MI, Meneses K, Busuttil RW, Wagener MM, Wheat LJ.

Transplantation. 2015 Dec;99(12):2543-50. doi: 10.1097/TP.0000000000000763.

PMID:
26050015
6.

Lack of correlation between Legionella colonization and microbial population quantification using heterotrophic plate count and adenosine triphosphate bioluminescence measurement.

Duda S, Baron JL, Wagener MM, Vidic RD, Stout JE.

Environ Monit Assess. 2015 Jul;187(7):393. doi: 10.1007/s10661-015-4612-5. Epub 2015 Jun 3.

PMID:
26038316
7.

Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes.

Singh N, Sifri CD, Silveira FP, Miller R, Gregg KS, Huprikar S, Lease ED, Zimmer A, Dummer JS, Spak CW, Koval C, Banach DB, Shroff M, Le J, Ostrander D, Avery R, Eid A, Razonable RR, Montero J, Blumberg E, Alynbiawi A, Morris MI, Randall HB, Alangaden G, Tessier J, Wagener MM, Sun HY.

Transplantation. 2015 Oct;99(10):2132-41. doi: 10.1097/TP.0000000000000690.

PMID:
25806406
8.

Evaluation of a new monochloramine generation system for controlling Legionella in building hot water systems.

Duda S, Kandiah S, Stout JE, Baron JL, Yassin M, Fabrizio M, Ferrelli J, Hariri R, Wagener MM, Goepfert J, Bond J, Hannigan J, Rogers D.

Infect Control Hosp Epidemiol. 2014 Nov;35(11):1356-63. doi: 10.1086/678418. Epub 2014 Sep 19.

PMID:
25333430
9.

Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.

Sun HY, Alexander BD, Huprikar S, Forrest GN, Bruno D, Lyon GM, Wray D, Johnson LB, Sifri CD, Razonable RR, Morris MI, Stosor V, Wagener MM, Singh N.

Clin Infect Dis. 2015 Jan 1;60(1):36-44. doi: 10.1093/cid/ciu711. Epub 2014 Sep 9. Erratum in: Clin Infect Dis. 2016 Jun 15;62(12):1621.

10.

Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.

Almaghrabi R, Clancy CJ, Doi Y, Hao B, Chen L, Shields RK, Press EG, Iovine NM, Townsend BM, Wagener MM, Kreiswirth B, Nguyen MH.

Antimicrob Agents Chemother. 2014 Aug;58(8):4443-51. doi: 10.1128/AAC.00099-14. Epub 2014 May 27.

11.

Tuberculosis in solid-organ transplant recipients: disease characteristics and outcomes in the current era.

Sun HY, Munoz P, Torre-Cisneros J, Aguado JM, Lattes R, Montejo M, Garcia-Reyne A, Bouza E, Valerio M, Lara R, Wagener MM, John GT, Bruno D, Singh N.

Prog Transplant. 2014 Mar;24(1):37-43. doi: 10.7182/pit2014398.

PMID:
24598564
12.

Immune reconstitution syndrome-like entity in lung transplant recipients with invasive aspergillosis.

Singh N, Suarez JF, Avery R, Lass-Flörl C, Geltner C, Pasqualotto AC, Lyon GM, Barron M, Husain S, Wagener MM, Montoya JG.

Transpl Immunol. 2013 Dec;29(1-4):109-13. doi: 10.1016/j.trim.2013.09.007. Epub 2013 Sep 25.

PMID:
24076039
13.

Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients.

Fukuta Y, Muder RR, Agha ME, Clarke LG, Wagener MM, Hensler AM, Doi Y.

Am J Infect Control. 2013 Dec;41(12):1249-52. doi: 10.1016/j.ajic.2013.04.003. Epub 2013 Jul 17.

PMID:
23870296
14.

Risk factors and outcomes in lung transplant recipients with nodular invasive pulmonary aspergillosis.

Singh N, Suarez JF, Avery R, Lass-Flörl C, Geltner C, Pasqualotto AC, Marshall Lyon G, Barron M, Husain S, Wagener MM, Montoya JG.

J Infect. 2013 Jul;67(1):72-8. doi: 10.1016/j.jinf.2013.03.013. Epub 2013 Apr 5.

PMID:
23567625
15.

Identifying the risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection among patients colonized with MRSA on admission.

Fukuta Y, Cunningham CA, Harris PL, Wagener MM, Muder RR.

Infect Control Hosp Epidemiol. 2012 Dec;33(12):1219-25. doi: 10.1086/668420. Epub 2012 Oct 23.

PMID:
23143359
16.

Lack of seasonality in the occurrence of multidrug-resistant Acinectobacter baumannii complex.

Fukuta Y, Clarke LG, Shields RK, Wagener MM, Pasculle AW, Doi Y.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):1051-2. doi: 10.1086/667741. Epub 2012 Aug 27. No abstract available.

17.

Prospective observational study of chronic rhinosinusitis: environmental triggers and antibiotic implications.

Ferguson BJ, Narita M, Yu VL, Wagener MM, Gwaltney JM Jr.

Clin Infect Dis. 2012 Jan 1;54(1):62-8. doi: 10.1093/cid/cir747. Epub 2011 Nov 22.

PMID:
22114094
18.

Impact of the duration of posttransplant renal replacement therapy on bacterial infections in liver transplant recipients.

Sun HY, Cacciarelli TV, Wagener MM, Singh N.

Liver Transpl. 2011 Oct;17(10):1212-7. doi: 10.1002/lt.22373.

19.

Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States.

Osawa R, Alexander BD, Forrest GN, Lyon GM, Somani J, del Busto R, Pruett TL, Sifri CD, Limaye AP, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Kalil AC, Garcia-Diaz J, Orloff SL, Houston SH, Wray D, Huprikar S, Johnson LB, Razonable RR, Fisher RA, Wagener MM, Husain S, Singh N.

Ann Transplant. 2010 Oct-Dec;15(4):77-83.

PMID:
21183881
20.

Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients.

Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N; Cryptococcal Collaborative Transplant Study Group.

Clin Infect Dis. 2010 Nov 1;51(9):1062-9. doi: 10.1086/656584.

PMID:
20879857
21.

Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients.

Sun HY, Cacciarelli TV, Wagener MM, Singh N.

Transpl Immunol. 2010 Aug;23(4):166-9. doi: 10.1016/j.trim.2010.06.013. Epub 2010 Jul 4.

PMID:
20609386
22.

Cutaneous cryptococcosis in solid organ transplant recipients.

Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Muñoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N; Cryptococcal Collaborative Transplant Study Group.

Med Mycol. 2010 Sep;48(6):785-91. doi: 10.3109/13693780903496617.

PMID:
20100136
23.

Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis.

Osawa R, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Muñoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N.

Transplantation. 2010 Jan 15;89(1):69-74. doi: 10.1097/TP.0b013e3181bcda41.

24.

Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care.

Feldman C, Alanee S, Yu VL, Richards GA, Ortqvist A, Rello J, Chiou CC, Chedid MB, Wagener MM, Klugman KP; International Pneumococcal Study Group.

Clin Microbiol Infect. 2009 Sep;15(9):850-7. doi: 10.1111/j.1469-0691.2009.02901.x.

25.

Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends.

Sun HY, Wagener MM, Singh N.

Clin Infect Dis. 2009 Jun 1;48(11):1566-76. doi: 10.1086/598936.

PMID:
19402789
26.

Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review.

Sun HY, Wagener MM, Singh N.

Am J Transplant. 2008 Oct;8(10):2111-8. doi: 10.1111/j.1600-6143.2008.02369.x. Review.

27.

Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings.

Singh N, Lortholary O, Dromer F, Alexander BD, Gupta KL, John GT, del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Wagener MM, Husain S; Cryptococcal Collaborative Transplant Study Group.

Transplantation. 2008 Sep 15;86(5):647-51. doi: 10.1097/TP.0b013e3181814e76.

28.

Dysregulated expression of T-helper cell responses and susceptibility to infections in high-risk liver transplant recipients.

Sun HY, Singh N, Cacciarelli TV, Wannstedt C, Wagener MM, Steele C.

Transpl Immunol. 2008 Nov;20(1-2):68-72. doi: 10.1016/j.trim.2008.08.001. Epub 2008 Aug 28.

PMID:
18761089
29.

Hepatic iron content and the risk of Staphylococcus aureus bacteremia in liver transplant recipients.

Singh N, Wannstedt C, Keyes L, Mayher D, Tickerhoof L, Akoad M, Wagener MM, Frye R, Cacciarelli TV.

Prog Transplant. 2007 Dec;17(4):332-6.

PMID:
18240700
30.

Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts.

Singh N, Wannstedt C, Keyes L, Mayher D, Tickerhoof L, Akoad M, Wagener MM, Cacciarelli TV.

Liver Transpl. 2008 Feb;14(2):240-4. doi: 10.1002/lt.21362.

31.

Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Yu VL, Hansen DS, Ko WC, Sagnimeni A, Klugman KP, von Gottberg A, Goossens H, Wagener MM, Benedi VJ; International Klebseilla Study Group.

Emerg Infect Dis. 2007 Jul;13(7):986-93. doi: 10.3201/eid1307.070187.

32.

Antifungal management practices in liver transplant recipients.

Singh N, Wagener MM, Cacciarelli TV, Levitsky J.

Am J Transplant. 2008 Feb;8(2):426-31. doi: 10.1111/j.1600-6143.2007.02089.x. Epub 2008 Jan 7.

33.

Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.

Singh N, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Muñoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Wagener MM, Husain S.

Clin Infect Dis. 2008 Jan 15;46(2):e12-8. doi: 10.1086/524738.

34.

Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis.

Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N.

Antimicrob Agents Chemother. 2008 Feb;52(2):735-8. Epub 2007 Dec 10.

35.

A survey of CMV prevention strategies after liver transplantation.

Levitsky J, Singh N, Wagener MM, Stosor V, Abecassis M, Ison MG.

Am J Transplant. 2008 Jan;8(1):158-61. Epub 2007 Oct 31.

36.

Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations.

Stout JE, Muder RR, Mietzner S, Wagener MM, Perri MB, DeRoos K, Goodrich D, Arnold W, Williamson T, Ruark O, Treadway C, Eckstein EC, Marshall D, Rafferty ME, Sarro K, Page J, Jenkins R, Oda G, Shimoda KJ, Zervos MJ, Bittner M, Camhi SL, Panwalker AP, Donskey CJ, Nguyen MH, Holodniy M, Yu VL; Legionella Study Group.

Infect Control Hosp Epidemiol. 2007 Jul;28(7):818-24. Epub 2007 Jun 5.

PMID:
17564984
37.

Bacteremia in lung transplant recipients in the current era.

Husain S, Chan KM, Palmer SM, Hadjiliadis D, Humar A, McCurry KR, Wagener MM, Singh N.

Am J Transplant. 2006 Dec;6(12):3000-7.

38.

Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality.

Singh N, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Wagener MM, Husain S; Cryptococcal Collaborative Transplant Study Group.

J Infect Dis. 2007 Mar 1;195(5):756-64. Epub 2007 Jan 23.

39.

Alternative therapy use in liver transplant recipients.

Tickerhoof L, Wagener MM, Cacciarelli TV, Singh N.

Prog Transplant. 2006 Sep;16(3):226-31.

PMID:
17007157
40.

Late-onset invasive aspergillosis in organ transplant recipients in the current era.

Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton PR, Del Busto R, Aguado JM, Wagener MM, Husain S.

Med Mycol. 2006 Aug;44(5):445-9.

PMID:
16882611
41.

Serotype and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from Taiwanese children: comparison of nasopharyngeal and clinical isolates.

Lauderdale TL, Wagener MM, Lin HM, Huang IF, Lee WY, Hseih KS, Lai JF, Chiou CC.

Diagn Microbiol Infect Dis. 2006 Dec;56(4):421-6. Epub 2006 Jul 28.

PMID:
16876978
42.

Systemic and cerebrospinal fluid T-helper cytokine responses in organ transplant recipients with Cryptococcus neoformans infection.

Singh N, Husain S, Limaye AP, Pursell K, Klintmalm GB, Pruett TL, Somani J, Stosor V, del Busto R, Wagener MM, Steele C.

Transpl Immunol. 2006 Aug;16(2):69-72. Epub 2006 Apr 19.

PMID:
16860707
43.

Invasive aspergillosis in the recipients of liver retransplantation.

Singh N, Pruett TL, Houston S, Muñoz P, Cacciarelli TV, Wagener MM, Husain S.

Liver Transpl. 2006 Aug;12(8):1205-9.

44.

Strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.

Singh N, Wagener MM.

Ann Intern Med. 2006 Mar 21;144(6):456-7; author reply 457. No abstract available.

PMID:
16549866
45.

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.

Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S.

Transplantation. 2006 Feb 15;81(3):320-6.

PMID:
16477215
46.

Impact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipients.

Singh N, Squier C, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV.

Infect Control Hosp Epidemiol. 2006 Feb;27(2):122-6. Epub 2006 Feb 8.

PMID:
16465627
47.

Isolation of Staphylococcus aureus from the urinary tract: association of isolation with symptomatic urinary tract infection and subsequent staphylococcal bacteremia.

Muder RR, Brennen C, Rihs JD, Wagener MM, Obman A, Stout JE, Yu VL.

Clin Infect Dis. 2006 Jan 1;42(1):46-50. Epub 2005 Nov 23.

PMID:
16323090
48.

A proactive approach to prevention of health care-acquired Legionnaires' disease: the Allegheny County (Pittsburgh) experience.

Squier CL, Stout JE, Krsytofiak S, McMahon J, Wagener MM, Dixon B, Yu VL.

Am J Infect Control. 2005 Aug;33(6):360-7.

PMID:
16061143
49.

Efficacy of new point-of-use water filter for preventing exposure to Legionella and waterborne bacteria.

Sheffer PJ, Stout JE, Wagener MM, Muder RR.

Am J Infect Control. 2005 Jun;33(5 Suppl 1):S20-5.

PMID:
15940113
50.

Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?

Singh N, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV.

Liver Transpl. 2005 Jun;11(6):700-4.

Supplemental Content

Loading ...
Support Center